Wei Ma
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Wei Ma has a total of 70 co-authors. Here are the top co-authors by number of shared publications:
Feng Liu
Department of Geriatric Medicine, Guangzhou First People's Hospital, South China University of Technology, Guangzhou, China
6 shared publicationsGang Xu
Department of Geriatric Medicine, The Second Affiliated Hospital, School of Medicine, South China University of Technology
6 shared publicationsCongrui Feng
Department of Geriatric Medicine, Guangzhou First People's Hospital, South China University of Technology, Guangzhou, China
5 shared publicationsJun Zhao
South China Univ Technol, Guangzhou Peoples Hosp 1, Dept Geriatr Resp Med, Guangzhou, Peoples R China
5 shared publicationsYuluo Chen
Department of Geriatric Medicine, Guangzhou First People's Hospital, South China University of Technology, Guangzhou, China
4 shared publicationsDanyan Cai
Department of Geriatric Medicine, Guangzhou First People's Hospital, South China University of Technology, Guangzhou, China
2 shared publications
Latest Publications
- Open Access
- 4 November 2026
- Published by Springer Nature in Current Allergy and Asthma Reports
- Vol. 26 (1) , 62
Asthma in Older Adults: A Systematic Review of Real-World Burden and Outcomes
- 4 November 2026
- Published by Springer Nature in Current Allergy and Asthma Reports
- Vol. 26 (1) , 62
Open AccessAsthma in Older Adults: A Systematic Review of Real-World Burden and Outcomes
- Open Access
- 2 April 2026
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 13, 1735311
Quantifying clinical indicators for identifying and prognosticating aspiration pneumonia in Chinese geriatric patients: a retrospective cohort study integrating multivariable regression and interpretable machine learning
Objective: Aspiration pneumonia (AP) substantially increases mortality risk among elderly patients, necessitating prompt diagnostic recognition and prognostic stratification. However, standardized diagnostic criteria and prognostic markers remain elusive. This investigation seeks to quantify high-contribution clinical parameters for the diagnosis and evaluation of AP prognosis, elucidate nonlinear risk interactions, and establish a comprehensive risk stratification framework tailored for Chinese geriatric populations. Methods: This retrospective cohort analysis (2017–2018) enrolled 295 patients with pneumonia (aged 65–98 years) from Guangzhou First People’s Hospital. The exposure variable was the diagnosis of AP, with the primary endpoints being 3-month mortality and recurrence rates. The adjustment variables encompassed demographic characteristics, comorbidities, biomarkers, and functional status. A dual-modeling approach was implemented: (1) multivariable multinomial logistic regression; (2) interpretable random forest algorithms incorporating SHAP/PDP analyses. Results: Conventional analytical approaches demonstrated significantly elevated 3-month mortality (17.3% vs. 5.9%) and recurrence rates (42.3% vs. 17.8%) in the AP cohort (both p < 0.001). We identified AP as an independent predictor using multinomial logistic regression of mortality (OR = 4.082, 95%CI: 1.041–15.997) and recurrence (OR = 3.329, 95%CI: 1.370–8.090). Regarding AP prognosis, consciousness impairment, muscle strength and swallowing function emerged as pivotal assessment indicators. Machine learning insights (AUC = 0.92) identified critical quantitative thresholds associated with AP classification, including in-hospital antibiotic duration >15 days and Barthel Index ≤2, along with nonlinear interaction effects between antibiotic duration and Barthel score; antibiotic duration was interpreted as a clinical-course marker rather than a causal factor. Additionally, prognostic quantitative markers for AP were established: albumin <30 g/L, with interactive effects between albumin levels and nutritional risk. Conclusion: This dual-framework methodology amalgamates epidemiological rigor with artificial intelligence interpretability, allowing AP identification and prognostic evaluation through routine clinical parameters. This approach establishes a foundation for dynamic risk stratification in AP patients and contributes to improved clinical outcomes.
- 2 April 2026
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 13, 1735311
Open AccessQuantifying clinical indicators for identifying and prognosticating aspiration pneumonia in Chinese geriatric patients: a retrospective cohort study integrating multivariable regression and interpretable machine learning
Objective: Aspiration pneumonia (AP) substantially increases mortality risk among elderly patients, necessitating prompt diagnostic recognition and prognostic stratification. However, standardized diagnostic criteria and prognostic markers remain elusive. This investigation seeks to quantify high-contribution clinical parameters for the diagnosis and evaluation of AP prognosis, elucidate nonlinear risk interactions, and establish a comprehensive risk stratification framework tailored for Chinese geriatric populations. Methods: This retrospective cohort analysis (2017–2018) enrolled 295 patients with pneumonia (aged 65–98 years) from Guangzhou First People’s Hospital. The exposure variable was the diagnosis of AP, with the primary endpoints being 3-month mortality and recurrence rates. The adjustment variables encompassed demographic characteristics, comorbidities, biomarkers, and functional status. A dual-modeling approach was implemented: (1) multivariable multinomial logistic regression; (2) interpretable random forest algorithms incorporating SHAP/PDP analyses. Results: Conventional analytical approaches demonstrated significantly elevated 3-month mortality (17.3% vs. 5.9%) and recurrence rates (42.3% vs. 17.8%) in the AP cohort (both p < 0.001). We identified AP as an independent predictor using multinomial logistic regression of mortality (OR = 4.082, 95%CI: 1.041–15.997) and recurrence (OR = 3.329, 95%CI: 1.370–8.090). Regarding AP prognosis, consciousness impairment, muscle strength and swallowing function emerged as pivotal assessment indicators. Machine learning insights (AUC = 0.92) identified critical quantitative thresholds associated with AP classification, including in-hospital antibiotic duration >15 days and Barthel Index ≤2, along with nonlinear interaction effects between antibiotic duration and Barthel score; antibiotic duration was interpreted as a clinical-course marker rather than a causal factor. Additionally, prognostic quantitative markers for AP were established: albumin <30 g/L, with interactive effects between albumin levels and nutritional risk. Conclusion: This dual-framework methodology amalgamates epidemiological rigor with artificial intelligence interpretability, allowing AP identification and prognostic evaluation through routine clinical parameters. This approach establishes a foundation for dynamic risk stratification in AP patients and contributes to improved clinical outcomes.
- Open Access
- 20 December 2025
- Published by Elsevier in Brain, Behavior, & Immunity - Health
- Vol. 51, 101164
Distinct actions of the humid heat environment on host gut microbiota, intestinal mucosal immunity, neuroendocrinology in influenza A virus-infected mouse
- 20 December 2025
- Published by Elsevier in Brain, Behavior, & Immunity - Health
- Vol. 51, 101164
Open AccessDistinct actions of the humid heat environment on host gut microbiota, intestinal mucosal immunity, neuroendocrinology in influenza A virus-infected mouse
- Open Access
- 12 September 2025
- Published by Wiley in General Psychiatry
- Vol. 38 (5)
Spermidine for cognitive ageing: insights into observational and interventional studies
- 12 September 2025
- Published by Wiley in General Psychiatry
- Vol. 38 (5)
Open AccessSpermidine for cognitive ageing: insights into observational and interventional studies
- Open Access
- 1 January 2024
- Published by SAGE Publications in Technology in Cancer Research & Treatment
- Vol. 23
Extracellular Vesicles Obtained From Lung Adenocarcinoma Cells Cultured Under Intermittent Hypoxia Induce M2 Macrophage Polarization via miR-20a-5p Delivery
Introduction: Intermittent hypoxia (IH), an important feature of obstructive sleep apnea, enhances the function of lung cancer cell-derived extracellular vesicles (EVs) to exacerbate the immunosuppressive properties of macrophages. Herein, we investigated the effects of EVs obtained from lung adenocarcinoma cells cultured under IH on macrophage polarization. Methods: The M1-type and M2-type tumor-associated macrophages (TAMs) in tissues from lung adenocarcinoma cases with (n = 10) or without (n = 12) OSA were assessed by immunohistochemical studies. EVs obtained from A549 cells grown under normoxia (EV-NA) or IH (EV-IH) were isolated and cocultured with macrophages. MicroRNA sequencing was used to determine discrepant miRNAs in EVs, selecting miR-20a-5p for subsequent experiments. Next, reverse transcription-quantitative polymerase chain reaction, flow cytometry, luciferase reporter assay, western blotting assay, and gain- and loss-of-function assays were used to explore the mechanism by which miR-20a-5p promotes M2 macrophage polarization by targeting phosphatase and Tensin homolog gene (PTEN). Results: Stromal M2 TAMs were highly abundant in patients with lung adenocarcinoma and obstructive sleep apnea. Macrophages treated with EV-IH that highly expressed miR-20a-5p showed the M2 phenotype. Luciferase reporter assay confirmed PTEN as a target of miR-20a-5p. Transfection of miR-20a-5p mimics decreased PTEN expression, upregulated M2 polarization markers, and promoted Akt phosphorylation in macrophages, while transfection with a miR-20a-5p inhibitor had the opposite effects. Furthermore, miR-20a-5p inhibition in macrophages eliminated the PTEN downregulation, Akt phosphorylation, and upregulation of M2 polarization markers induced by EV-IH transfection. Conclusion: These findings indicate that EVs obtained from lung adenocarcinoma cells cultured under IH deliver miR-20a-5p to promote M2 macrophage polarization by targeting PTEN.
- 1 January 2024
- Published by SAGE Publications in Technology in Cancer Research & Treatment
- Vol. 23
Open AccessExtracellular Vesicles Obtained From Lung Adenocarcinoma Cells Cultured Under Intermittent Hypoxia Induce M2 Macrophage Polarization via miR-20a-5p Delivery
Introduction: Intermittent hypoxia (IH), an important feature of obstructive sleep apnea, enhances the function of lung cancer cell-derived extracellular vesicles (EVs) to exacerbate the immunosuppressive properties of macrophages. Herein, we investigated the effects of EVs obtained from lung adenocarcinoma cells cultured under IH on macrophage polarization. Methods: The M1-type and M2-type tumor-associated macrophages (TAMs) in tissues from lung adenocarcinoma cases with (n = 10) or without (n = 12) OSA were assessed by immunohistochemical studies. EVs obtained from A549 cells grown under normoxia (EV-NA) or IH (EV-IH) were isolated and cocultured with macrophages. MicroRNA sequencing was used to determine discrepant miRNAs in EVs, selecting miR-20a-5p for subsequent experiments. Next, reverse transcription-quantitative polymerase chain reaction, flow cytometry, luciferase reporter assay, western blotting assay, and gain- and loss-of-function assays were used to explore the mechanism by which miR-20a-5p promotes M2 macrophage polarization by targeting phosphatase and Tensin homolog gene (PTEN). Results: Stromal M2 TAMs were highly abundant in patients with lung adenocarcinoma and obstructive sleep apnea. Macrophages treated with EV-IH that highly expressed miR-20a-5p showed the M2 phenotype. Luciferase reporter assay confirmed PTEN as a target of miR-20a-5p. Transfection of miR-20a-5p mimics decreased PTEN expression, upregulated M2 polarization markers, and promoted Akt phosphorylation in macrophages, while transfection with a miR-20a-5p inhibitor had the opposite effects. Furthermore, miR-20a-5p inhibition in macrophages eliminated the PTEN downregulation, Akt phosphorylation, and upregulation of M2 polarization markers induced by EV-IH transfection. Conclusion: These findings indicate that EVs obtained from lung adenocarcinoma cells cultured under IH deliver miR-20a-5p to promote M2 macrophage polarization by targeting PTEN.
- Open Access
- 1 March 2023
- Published by AME Publishing Company in Journal of Thoracic Disease
- Vol. 15 (3) , 1177-1185
Features of osteoporosis in male patients with bronchiectasis, a cross-sectional study
Original Article Features of osteoporosis in male patients with bronchiectasis, a cross-sectional study Gang Xu, Jun Zhao, Feng Liu, Danyan Cai, Congrui Feng, Liuqian Wang, Yanjun Zeng, Yuanling Liu, Sizhi Wu, Yuluo Chen, Wei Ma
- 1 March 2023
- Published by AME Publishing Company in Journal of Thoracic Disease
- Vol. 15 (3) , 1177-1185
Open AccessFeatures of osteoporosis in male patients with bronchiectasis, a cross-sectional study
Original Article Features of osteoporosis in male patients with bronchiectasis, a cross-sectional study Gang Xu, Jun Zhao, Feng Liu, Danyan Cai, Congrui Feng, Liuqian Wang, Yanjun Zeng, Yuanling Liu, Sizhi Wu, Yuluo Chen, Wei Ma
- 29 December 2022
- Published by Ant Publishing in Aging Pathobiology and Therapeutics
- Vol. 4 (4) , 138-139
On the frontier of chronic obstructive pulmonary disease—an interview with Prof. Peter J Barnes
The article is an interview with Prof. Peter J Barnes of the National Heart and Lung Institute, previously Head of Respiratory Medicine at Imperial College, conducted by Wei Ma of the Department of Geriatric Respiratory Medicine, Guangzhou First People’s Hospital, on behalf of Aging Pathobiology and Therapeutics.
- 29 December 2022
- Published by Ant Publishing in Aging Pathobiology and Therapeutics
- Vol. 4 (4) , 138-139
On the frontier of chronic obstructive pulmonary disease—an interview with Prof. Peter J Barnes
The article is an interview with Prof. Peter J Barnes of the National Heart and Lung Institute, previously Head of Respiratory Medicine at Imperial College, conducted by Wei Ma of the Department of Geriatric Respiratory Medicine, Guangzhou First People’s Hospital, on behalf of Aging Pathobiology and Therapeutics.
- Open Access
- 9 February 2021
- Published by Frontiers Media SA in Frontiers in Public Health
- Vol. 9, 616963
Clinical Characteristics and CT Findings in 148 Non-COVID-19 Influenza-Like Illness Cases: A Retrospective Control Study
Background: This study was to collect clinical features and computed tomography (CT) findings of Influenza-Like Illness (ILI) cases, and to evaluate the correlation between clinical data and the abnormal chest CT in patients with the Influenza-Like Illness symptoms.Methods: Patients with the Influenza-Like Illness symptoms who attended the emergency department of The Six Medical Center of The PLA General Hospital from February 10 to April 1, 2020 were enrolled. Clinical and imaging data of the enrolled patients were collected and analyzed. The association between clinical characteristics and abnormal chest CT was also analyzed.Results: A total of 148 cases were enrolled in this study. Abnormalities on chest CT were detected in 61/148 (41.2%) patients. The most common abnormal CT features were as follows: patchy consolidation 22/61(36.1%), ground-glass opacities 21/61(34.4%), multifocal consolidations 17/61(27.9%). The advanced age and underlying diseases were significantly associated with abnormal chest CT.Conclusions: Abnormal chest CT is a common condition in Influenza-Like Illness cases. The presence of advanced age and concurrent underlying diseases is significantly associated with abnormal chest CT findings in patients with ILI symptoms. The chest CT characteristic of ILI is different from the manifestation of COVID-19 infection, which is helpful for differential diagnosis.
- 9 February 2021
- Published by Frontiers Media SA in Frontiers in Public Health
- Vol. 9, 616963
Open AccessClinical Characteristics and CT Findings in 148 Non-COVID-19 Influenza-Like Illness Cases: A Retrospective Control Study
Background: This study was to collect clinical features and computed tomography (CT) findings of Influenza-Like Illness (ILI) cases, and to evaluate the correlation between clinical data and the abnormal chest CT in patients with the Influenza-Like Illness symptoms.Methods: Patients with the Influenza-Like Illness symptoms who attended the emergency department of The Six Medical Center of The PLA General Hospital from February 10 to April 1, 2020 were enrolled. Clinical and imaging data of the enrolled patients were collected and analyzed. The association between clinical characteristics and abnormal chest CT was also analyzed.Results: A total of 148 cases were enrolled in this study. Abnormalities on chest CT were detected in 61/148 (41.2%) patients. The most common abnormal CT features were as follows: patchy consolidation 22/61(36.1%), ground-glass opacities 21/61(34.4%), multifocal consolidations 17/61(27.9%). The advanced age and underlying diseases were significantly associated with abnormal chest CT.Conclusions: Abnormal chest CT is a common condition in Influenza-Like Illness cases. The presence of advanced age and concurrent underlying diseases is significantly associated with abnormal chest CT findings in patients with ILI symptoms. The chest CT characteristic of ILI is different from the manifestation of COVID-19 infection, which is helpful for differential diagnosis.
- Open Access
- 30 November 2020
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 7, 593133
No Evidence of Re-infection or Person-to-Person Transmission in Cured COVID-19 Patients in Guangzhou, a Retrospective Observational Study
Objectives: To clarify the clinical characteristics of cured patients with coronavirus disease (COVID-19), and to clarify the re-infection and person-to-person transmission in the cured.Methods: A total of 187 cured COVID-19 patients with antibody test were followed up every 2 weeks in this retrospective observational study. Assessment for general condition, symptoms, epidemiological contact history, polymerase chain reaction (PCR) assay, and antibody tests were performed and recorded. Information from Guangzhou CDC was also screened.Results: There were 33 (17.6%) patients with negative results for IgG and 35 (18.7%) patients with positive results for IgM. The average days of antibody detection from disease onset were 53.0. PCR assay was positive in 10 (5.3%) patients during the follow-up. Neither IgG nor IgM results showed a relationship with PCR test results (all P > 0.05). Neither re-infection nor person-to-person transmission was found in the cured patients. Factors associated with appearance of antibody comprised hospitalization days (OR: 1.06, 95%CI: 1.02–1.11, P = 0.006) and antibiotics treatment (OR: 3.50, 95%CI: 1.40–8.77, P = 0.007).Conclusions: In our study, no evidence of person-to-person transmission was found in cured COVID-19 patients. There seemed to be no re-infection in the cured COVID-19 patients in Guangzhou. These finding suggest that the cured do not cause the spread of disease. Additionally, neither IgG nor IgM can be used to replace the PCR test in cured patients.
- 30 November 2020
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 7, 593133
Open AccessNo Evidence of Re-infection or Person-to-Person Transmission in Cured COVID-19 Patients in Guangzhou, a Retrospective Observational Study
Objectives: To clarify the clinical characteristics of cured patients with coronavirus disease (COVID-19), and to clarify the re-infection and person-to-person transmission in the cured.Methods: A total of 187 cured COVID-19 patients with antibody test were followed up every 2 weeks in this retrospective observational study. Assessment for general condition, symptoms, epidemiological contact history, polymerase chain reaction (PCR) assay, and antibody tests were performed and recorded. Information from Guangzhou CDC was also screened.Results: There were 33 (17.6%) patients with negative results for IgG and 35 (18.7%) patients with positive results for IgM. The average days of antibody detection from disease onset were 53.0. PCR assay was positive in 10 (5.3%) patients during the follow-up. Neither IgG nor IgM results showed a relationship with PCR test results (all P > 0.05). Neither re-infection nor person-to-person transmission was found in the cured patients. Factors associated with appearance of antibody comprised hospitalization days (OR: 1.06, 95%CI: 1.02–1.11, P = 0.006) and antibiotics treatment (OR: 3.50, 95%CI: 1.40–8.77, P = 0.007).Conclusions: In our study, no evidence of person-to-person transmission was found in cured COVID-19 patients. There seemed to be no re-infection in the cured COVID-19 patients in Guangzhou. These finding suggest that the cured do not cause the spread of disease. Additionally, neither IgG nor IgM can be used to replace the PCR test in cured patients.
- 24 July 2020
- Published by Springer Nature in GeroScience
- Vol. 42 (5) , 1225-1227
New view on older adults with COVID-19: comments on “SARS-CoV-2 and COVID-19 in older adults: what we may expect regarding pathogenesis, immune responses, and outcomes”
- 24 July 2020
- Published by Springer Nature in GeroScience
- Vol. 42 (5) , 1225-1227
New view on older adults with COVID-19: comments on “SARS-CoV-2 and COVID-19 in older adults: what we may expect regarding pathogenesis, immune responses, and outcomes”